Suppliers / Newland Pharmaceutical

Newland Pharmaceutical

China Updated 9 July 2026

Newland Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Fondaparinux US FDA 1
Moxifloxacin US FDA 1

Also appears on these molecule pages

Fondaparinux API Moxifloxacin API

Questions about Newland Pharmaceutical

Does Newland Pharmaceutical hold a US DMF or a CEP?
Newland Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Newland Pharmaceutical make?
2 molecules are on record against Newland Pharmaceutical, including Fondaparinux and Moxifloxacin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Newland Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Apitoria Pharma shares 2 molecules Dr Reddy's Laboratories shares 2 molecules Hetero shares 1 molecule Olon shares 1 molecule Macleods Pharmaceuticals shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability